Sodium Nitroprusside in Sex-Aware Vascular Assays
2026-09-09
Use Sodium Nitroprusside as a controlled nitric oxide donor to separate vascular smooth muscle responsiveness from the systemic effects of angiotensin II hypertension. This workflow combines fresh-solution handling, sex-stratified vessel testing, telemetry-informed interpretation, and platelet assay controls for more reproducible cardiovascular research.
EZ Cap™ Cy5 EGFP mRNA: A Delivery Assay
2026-09-08
Discover how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates mRNA uptake from productive translation in advanced delivery studies. This article develops a dual-signal framework for interpreting nanoparticle performance, intracellular release, and reporter expression.
Fenofibrate, PPARα-YAP Signaling, and Aging Liver
2026-09-08
A 2025 study in Chemico-Biological Interactions shows that Fenofibrate induces comparable liver enlargement and PPARα-YAP pathway activation in adult and aging mice. By combining chemically induced, naturally aged, and senescence-accelerated models, the work suggests that this hepatic response is largely preserved with age while clarifying important considerations for metabolic and aging research.
SCH772984: Selective ERK1/2 Inhibitor Guide
2026-09-07
SCH772984 is an ATP-competitive ERK1/2 inhibitor with nanomolar biochemical potency and reported activity in BRAF, NRAS, and KRAS mutant tumor models. Its strongest use is as a selective MAPK/ERK pathway inhibition tool, while its application to NPC radioresistance remains a testable hypothesis rather than an established result.
BMS 599626 dihydrochloride in EGFR Research
2026-09-05
BMS 599626 dihydrochloride is a nanomolar EGFR and ErbB2 inhibitor for separating receptor phosphorylation, downstream proliferation, and tumor-model responses. This workflow-focused guide shows how to build concentration-response assays, validate HER1/HER2 pathway suppression, and cautiously connect oncology experiments with machine-learning-guided senescence research.
Rotigotine Workflows for Parkinson’s Disease Research
2026-09-05
Build more reproducible Rotigotine experiments by connecting dopamine-receptor pharmacology with oxidative-stress, neuroprotection, behavioral, and nose-to-brain delivery readouts. This practical workflow uses the reference study to show when free compound, continuous exposure, or chitosan nanoparticle delivery is the better experimental choice.
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-04
Saito and colleagues developed a streamlined three-dimensional culture strategy for generating human induced pluripotent stem cell-derived intestinal organoids with sustained expansion, differentiation potential, and cryopreservation compatibility. The resulting organoid-derived epithelial cells contained functional enterocytes with cytochrome P450 metabolism and transporter activity, supporting more human-relevant in vitro pharmacokinetic studies.
3-Deazaadenosine in Methylation Research
2026-09-04
3-Deazaadenosine provides a time-controlled way to perturb cellular methylation through S-adenosylhomocysteine hydrolase inhibition. This article translates that mechanism into workflows for UC inflammation, RNA methylation, and carefully contained preclinical antiviral research, with practical controls and troubleshooting guidance.
HOBt: Reaction Control from Coupling to Discovery
2026-09-03
HOBt (1-Hydroxybenzotriazole) is more than a peptide coupling additive: it can shape reaction selectivity, analytical strategy, and medicinal-chemistry route design. This article interprets its role through a glucagon receptor antagonist synthesis and translates that evidence into practical workflow decisions.
MG-262: Reversible Proteasome Inhibitor
2026-09-03
MG-262, also called Z-Leu-Leu-Leu-B(OH)2, is a cell-permeable, reversible inhibitor of proteasome chymotryptic activity. It supports proteasome inhibition assay design, apoptosis research, and studies of protein homeostasis when interpreted alongside appropriate pathway controls.
gamma-Glu-Cys (γ-Glu-Cys) Workflow Guide
2026-09-02
gamma-Glu-Cys (γ-Glu-Cys) provides a defined, soluble intermediate for glutathione synthetase enzyme assays, glutathione metabolism research, and selected peptide workflows. It is intended for controlled scientific use with freshly prepared solutions, not for diagnostic, clinical, or medical applications.
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-02
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based assays. It is intended for research workflows such as in situ hybridization and Northern blot hybridization, not for diagnostic, clinical, or therapeutic use.
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-01
The Tricine-SDS-PAGE Gel Preparation Kit is designed to improve separation of low-molecular-weight proteins and peptides, including targets in the 1–10 kDa range that can be difficult to resolve by conventional Tris-SDS-PAGE. It is intended for research protein electrophoresis and should not be used for diagnostic, clinical, or medical applications.
MK 0893 Glucagon Receptor Antagonist Workflows
2026-09-01
Build stronger GCGR assays with MK 0893, a competitive, reversible glucagon receptor antagonist that connects receptor pharmacology to cAMP signaling and metabolic phenotyping. This guide emphasizes practical dosing, assay controls, formulation, selectivity testing, and troubleshooting for type 2 diabetes research.
HyperScribe T7 High Yield RNA Synthesis Kit
2026-08-31
This scenario-driven guide explains how SKU K1047 can standardize RNA inputs for cell viability, proliferation, and cytotoxicity workflows. It covers T7 RNA polymerase transcription, modified and labeled transcripts, protocol planning, data interpretation, and practical vendor selection.
507 records 9/34 page Previous Next First page 上5页 678910 下5页 Last page